GSK plc (GLAXF)
OTCMKTS
· Delayed Price · Currency is USD
18.58
+0.08 (0.43%)
May 12, 2025, 11:56 AM EDT
GSK plc Revenue
GSK plc had revenue of 7.52B GBP in the quarter ending March 31, 2025, with 2.08% growth. This brings the company's revenue in the last twelve months to 31.53B, up 2.57% year-over-year. In the year 2024, GSK plc had annual revenue of 31.38B with 3.46% growth.
Revenue (ttm)
31.53B GBP
Revenue Growth
+2.57%
P/S Ratio
1.84
Revenue / Employee
459.41K GBP
Employees
68,629
Market Cap
75.14B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
GSK plc News
- 3 days ago - GSK and Lifetime® launch original movie to raise awareness about the impact of meningitis - Business Wire
- 4 days ago - GSK met main goal in liver disease treatment trial - Seeking Alpha
- 4 days ago - EU drugs regulator confirms suicidal thoughts as side effect of anti hair-loss drug - Reuters
- 6 days ago - Pfizer, GSK RSV shot recommendations under scrutiny from RFK Jr. aide - report - Seeking Alpha
- 7 days ago - 5 Reasons GSK Looks Good - Seeking Alpha
- 8 days ago - GSK declares $0.4216 dividend - Seeking Alpha
- 11 days ago - Blueprint Medicines Reports First Quarter 2025 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance - Benzinga
- 12 days ago - Healthy Returns: Here are the drugmakers with new U.S. investments as Trump's pharma tariffs loom - CNBC